Controversies in Neonatal Thrombotic Disorders

Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 58-74

  Manco Johnson, Marilyn J ^a  

^a Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58649088694     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603158-1.10005-8     Document Type: Chapter

References (128)

1. MJ Manco-Johnson (2005) Etiopathogenesis of pediatric thrombosis. Hematology 10(suppl 1), 167
2. JM Journeycake and MJ Manco-Johnson (2004) Thrombosis during infancy and childhood: what we know and what we do not know. Hematol Clinics North Am 18 1315
3. U Nowak-Gottl, R von Kries and U Gobel (1997) Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child 76 F163
4. CH Van Ommen, H Heijboer, H Buller, et al. (2001) Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatrics 139 676-681
5. B Schmidt and M Andrew (1995) Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96 939-943
6. K Kurnik, A Kosch, R Strater, et al. (2003) for the Childhood Stroke Study Group. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke. A prospective follow-up study. Stroke 34 2887
7. MJ Manco-Johnson (2005) Development of hemostasis in the fetus. Thromb Res 115(Suppl 1), P55
8. P Reverdiau-Moalic, B Delahousse, G Body, et al. (1996) Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 88(3), 900-906
9. M Andrew, B Paes, R Milner, et al. (1987) Development of the human coagulation system in the full-term infant. Blood 70(1), 165-172
10. M Andrew, P Vegh, M Johnston, et al. (1992) Maturation of the hemostatic system during childhood. Blood 80(8), 1998-2005
11. DJ Bowen and PW Collins (2006) Insights into von Willebrand factor proteolysis: clinical implications. Br J Haematol 133(5), 457-467
12. MJ Weinstein, R Blanchard, JL Moake, et al. (1989) Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 72(1), 68-72
13. K Kavakli, MT Canciani and PM Mannucci (2002) Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children. Pediatr Hematol Oncol 19 467-473
14. HM Tsai, R Sarode and KA Downes (2002) Ultralarge von Willebrand factor multimers and normal ADAMTS activity in the umbilical cord blood. Thromb Res 108 121-125
15. SJ Israels, ML Rand and AD Michelson (2003) Neonatal platelet function. Semin Thromb Hemost 29 363-372
16. MA Saxonhouse and MC Sola (2004) Platelet function in term and preterm neonates. Clin Perinatol 31 15-28
17. A Del Vecchio and MC Sola (2000) Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol 27 643-654
18. ML Rand, MD Carcao and VS Blanchette (1998) Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting. Semin Thromb Hemost 24 523-529
19. D Sthoeger, M Nardi and M Karpatkin (1989) Protein S in the first year of life. Br J Haematol 72 424-428
20. JJ Corrigan Jr and MA Jeter (1990) Histadine-rich glycoprotein and plasminogen plasma levels in term and preterm newborns. Am J Dis Child 144 825-828
21. WE Hathaway and J. Bonnar (1987) Hemostatic disorders of the pregnant woman and newborn infant New York, NY: Elsevier 60-61
22. M Ries (1997) Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period. Semin Thromb Hemost 23 247-252
23. M Markarian, JH Githens, E Rosenblut, et al. (1971) Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. I. Coagulation studies. Biol Neonate 17 84-97
24. W Streif, B Paes, L Berry, et al. (2000) Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns. Blood Coagul Fibrinolysis 11(4), 349-357
25. G Cvirn, S Gallistl, B Leschnik, et al. (2003) Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 1(2), 263-268
26. NA Goldenberg, WE Hathaway, L Jacobson, et al. (2005) A new global assay of coagulation and fibrinolysis. Thromb Res 116 345-356
27. AA Smith, LJ Jacobson, BI Miller, et al. (2003) A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res 112 329-337
28. M Markarian, JH Githens, JJ Jackson, et al. (1967) Fibrinolytic activity in premature infants. Relationship of the enzyme system to the respiratory distress syndrome. Am J Dis Child 113(3), 312-321
29. MJ Manco-Johnson (1994) Disseminated intravascular coagulation and other hypercoagulable syndromes. Int J Pediatr Hematol Oncol 1 1-23
30. MM McDonald, ML Johnson, CM Rumack, et al. (1984) Role of coagulopathy in newborn intracranial hemorrhage. Pediatrics 74(1), 26-31
31. MJ Manco-Johnson, RA Marlar, LJ Jacobson, et al. (1988) Severe protein C deficiency in newborn infants. J Pediatr 113 359-363
32. MJ Manco-Johnson, TC Abshire, LJ Jacobson, et al. (1991) Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 119 793-798
33. NA Goldenberg and MJ Manco-Johnson (2006) Pediatric hemostasis and use of plasma components. Best Prac Res Clin Haematol 19 143-155
34. B Schmidt, P Gillie, L Mitchell, et al. (1998) A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 158 470-476
35. B Goldstein, S Nadel, M Peters, et al. (2006) ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. Pediatr Crit Care Med 7 277-278
36. J Petaja, K Peltola and P Rautiainen (1999) Disappearance of symptomatic venous thrombosis after neonatal cardiac operations during antithrombin II substitution. J Thorac Cardiovasc Surg 118 955-956
37. EH Oppenheimer and JR Esterly (1965) Thrombosis in the newborn: comparison between infants of diabetic and nondiabetic mothers. J Pediatr 67 549-556
38. PJD Winyard, T Bharucha, R De Bruyn, et al. (2006) Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed 91 273-278
39. JT Van Horn, C Craven, K Ward, et al. (2004) Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25(7), 642-648
40. FR Rosendaal (2005) Venous thrombosis: the role of genes, environment and behavior. Hematology Am soc Hematol State of the Art 1-12
41. RA Kraaijenhagen, PS In't Anker, MM Koopman, et al. (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83 5-9
42. B Zoller, A Hillarp, E Berntorp, et al. (1997) Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis. Annu Rev Med 48 45-58
43. SR Poort, FR Rosendaal, PH Reitsma, et al. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 3698-3703
44. M Den Heijer, T Koster, HJ Blom, et al. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334(12), 759-762
45. JL Rook, DJ Nugent and G Young (2005) Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations. J Pediatr Hematol Oncol 27(11), 590-593
46. G Brenner (2006) Thrombophilia and adverse pregnancy outcome. Obstet Gynecol Clin North Am 33(3), 443-456., ix
47. JC Meijers, WL Tekelenburg, BN Bouma, et al. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342 696-701
48. A Van Hylckama Vlieg, IK van der Linden, RM Bertina, et al. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood 95(12), 3678-3682
49. P Bucciarelli, FR Rosendaal, A Tripodi, et al. (1999) Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol 19(4), 1026-1033
50. J Petaja and MJ Manco-Johnson (2003) Protein C pathway in infants and children. Semin Thromb Hemost 29 349-361
51. MJ Manco-Johnson and R Nuss (2001) Thrombophilia in the infant and child. Adv Pediatr 48 363-384
52. A Kosch, E Kuwertz-Bröking, C Heller, et al. (2004) Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 104 1356-1360
53. CH Van Ommen and M Peters (2003) Venous thromboembolic disease in childhood. Semin Thromb Hemost 29 391-403
54. JN Hagstrom, J Walter, R Bluebond-Langner, et al. (1998) Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 133 777-781
55. CY Vossen, FE Preston, J Conard, et al. (2004) Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost 2 592-596
56. B Brenner, EF Grabowski, M Hellgren, et al. (2004) Thrombophilia and pregnancy complications. Thromb Haemost 92 678-681
57. FR Rosendaal (1999) Venous thrombosis: a multicausal disease. The Lancet 353 1167-1173
58. L Robertson, O Wu, P Langhorne, et al. (2006) Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 171-196
59. WH Kutteh (1997) Antiphospholipid antibodies and reproduction. J Reprod Immunol 35 151-171
60. OL deKlerk, TW deVries and LG Sinnige (1997) An unusual case of neonatal seizures in a newborn infant. Pediatrics 100 E8
61. MC Hermansen and MG Hermansen (2005) Intravascular catheter complications in the neonatal intensive care unit. Clin Perinatol 32 141-156,vii
62. JE Tyson, DJ deSa and S Moore (1976) Thromboatheromatous complications of umbilical arterial catheterization in the newborn period. Clinicopathological study. Arch Dis Child 51 744-754
63. DS Schwartz, PA Gettner, MM Konstantino, et al. (1997) Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 131 760-762
64. JH Kim, YS Lee, SH Kim, et al. (2001) Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 219 645-650
65. I Morag, M Epelman, A Daneman, et al. (2006) Portal vein thrombosis in the neonate: risk factors, course and outcome. J Pediatr 148 745-749
66. M Butler-O'Hara, CJ Buzzard, L Reubens, et al. (2006) A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 118 e25-e35
67. M Salonvaara, P Riikonen, R Kekomaki, et al. (1999) Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 88 642-646
68. P Shah and V Shah (2005) Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Sys Rev 3
69. J Petäjä, U Lundström, H Sairanen, et al. (1996) Central venous thrombosis after cardiac operations in children. J Thorac Cariovasc Surg 112 883-889
70. U Nowak-Göttl, A Dübbers, D Kececioglu, et al. (1997) Factor V Leiden, protein C and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 131 608-612
71. KJ Barrington (1999) Umbilical artery catheters in the newborn: effects of catheter materials. Cochrane Database Sys Rev 1 Art. No.: CD000949. DOI: 10.1002/14651858.CD000949
72. J Gilhooly, J Lindenberg and JW Reynolds (1986) Central venous silicone elastomer catheter placement by basilic vein cutdown in neonates. Pediatrics 78 636-639
73. KJ Barrington (1999) Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Sys Rev 1 Art. No.: CD000505. DOI: 10.1002/14651858.CD000505
74. MF Goutail-Flaud, M Sfez, A Berg, et al. (1991) Central venous catheter-related complications in newborns and infants: a 587-case survey. J Pediatr Surg 26 645-650
75. HF Sadiq, S Devaskar, WJ Keenan and TR Weber (1987) Broviac catheterization in low birth weight infants: incidence and treatment of associated complications. Crit Care Med 15 47-50
76. KJ Barrington (1999) Umbilical artery catheters in the newborn: effects of catheter design (end vs side hole). Cochrane Database Sys Rev 1 Art. No.: CD000508. DOI: 10.1002/14651858.CD000508
77. NS Kabra, M Kumar and SS Shah (2005) Multiple versus single lumen umbilical venous catheters for newborn infants. Cochrane Database Sys Rev 3 Art. No.: CD004498. DOI: 10.1002/14651858.CD004498
78. KJ Barrington (1999) Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database Sys Rev 1 Art. No.: CD000507. DOI: 10.1002/14651858.CD000507
79. JC Jackson, WE Truog, JF Watchko, et al. (1987) Efficacy of thromboresistant umbilical artery catheters in reducing aortic thrombosis and related complications. J Pediatr 110 102-105
80. CM Pierce, A Wade and Q Mok (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intens Care Med 26 967-972
81. P Klement, YJ Du, LR Berry, et al. (2006) Chronic performance of polyurethane catheters covalently coated with ATH complex: a rabbit jugular vein model. Biomaterials 27 5107-5117
82. M Blaney, V Shen, JA Kerner, et al. (2006) for the CAPS investigators. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (the Cathflo Activate Pediatric Study). J Vasc Interv Radiol 17 1745-1751
83. BR Jacobs, M Haygood and J Hingl (2001) Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 139 593-596
84. EA Chalmers (2005) Perinatal stroke – risk factors and management. Brit J Haematol 130 333-343
85. J Lee, LA Croen, KH Backstrand, et al. (2005) Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 292 723-729
86. G deVeber (2000) Canadian paediatric ischaemic stroke registry: analysis of children with arterial ischaemic stroke. The Canadian Pediatric Stroke Study Group. Ann Neurol 48 526., abstr
87. MR Golomb, DL MacGregor, T Domi, et al. (2001) Presumed pre- or perinatal arterial ischemic stroke: risk factors and outcomes. Ann Neurol 50 163-168
88. G deVeber and M Andrew (2001) Cerebral sinovenous thrombosis in children. New Engl J Med 345 417-423
89. K Kurnik, A Kosch, R Sträter, et al. (2003) for the Childhood Stroke Study Group. Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke. a prospective follow-up study. Stroke 34 2887-2893
90. MR Golomb, PT Dick, DL MacGregor, et al. (2004) Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. J Child Neurol 19 493-497
91. E Mecuri, A Barnett, M Rutherford, et al. (2004) Neonatal cerebral infarction and neuromotor outcome at school age. Pediatrics 113 95-100
92. G Günther, R Junker, R Sträter, et al. (2000) for the Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke 31 2437-2441
93. G deVeber, P Monagle, A Chan, et al. (1998) Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 55 1539-1543
94. MJ Parker, GI Joubert and SD Levin (2002) Portal vein thrombosis causing neonatal cerebral infarction. Arch Dis Child Fetal Neonatal Ed 87 125-127
95. MA Rutherford, P Ward and C Malamatentiou (2005) Advanced MR techniques in the term-born neonate with perinatal brain injury. Semin Fetal Neonatal Med 10 445-460
96. FM Cowan and LS deVries (2005) The internal capsule in neonatal imaging. Semin Fetal Neonatal Med 10 461-474
97. JP Boardman, V Ganesan, MA Rutherford, et al. (2005) Magnetic resonance imaging correlates of hemiparesis after perinatal and childhood middle cerebral artery stroke. Pediatrics 115 321-326
98. J Stam, S deBruijn and G deVeber (2003) Anticoagulation for cerebral sinus thrombosis. Stroke 34 1054-1055
99. P Monagle, A Chan, P Massicotte, et al. (2004) Antithrombotic therapy in children. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 645S-687S
100. JL Saver and B Yafeh (2007) Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. Stroke 38 414-416
101. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007, in print: prepublished online November 16, 2006; DOI 10.1182/blood-2006–09–003004
102. AR Folsom, WD Rosamond, E Shahar, et al. (1999) Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 199 736-742
103. BV Zlokovic, C Zhang, D Liu, et al. (2005) Functional recovery after embolic stroke in rodents by activated protein C. Ann Neurol 58 474-477
104. M Endres, U Laufs, J Liao, et al. (2004) Targeting eNOS for stroke protection. Trends Neurosci 27 283-289
105. M Cimino, W Balduini, S Carloni, et al. (2005) Neuroprotective effect of Simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neuro Toxicology 26 929-933
106. A-L Siren, M Fratelli, M Brines, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98 4044-4049
107. TC Wen, Y Sadamoto, J Tanaka, et al. (2002) Erythopoietin protects neurons against chemical hypoxia and cerebral ischemic injury by upregulating Bcl-xL expression. J Neurosci Res 67 795-803
108. ST Carmichael (2006) Cellular and molecular mechanisms of neural repair after stroke: Making waves. Ann Neurol 59 735-742
109. A Sola, M Rogido, BH Lee, et al. (2005) Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 57 481-487
110. R Ohls, RA Ehrenkranz, A Das, et al. (2004) for the National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114 1287-1291
111. R Bierer, MC Peceny, CH Hartenberger, et al. (2006) Erythropoietin and neurodevelopmental outcome in preterm infants. Pediatrics 118 e635-e640
112. J Chao and L Chao (2004) Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp Physiol 90(3), 291-298
113. MJ Manco-Johnson (2006) How I treat venous thrombosis in children. Blood 107 21-29
114. S Revel-Vilk, A Sharanthkumar, P Massicotte, et al. (2004) Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost 2 42-46
115. MM McDonald, LJ Jacobson, WW Hay JR, et al. (1981) Heparin clearance in the newborn. Pediatr Res 15 1015-1018
116. MM McDonald and WE Hathaway (1982) Anticoagulant therapy by continuous heparininzation in newborn and older infants. J Pediatr 101 451-457
117. KK Dunaway, P Gal and JL Ransom (2000) Use of enoxaparin in a preterm infant. Ann Pharmacother 34(12), 1410-1413
118. M Albisetti (2006) Thrombolytic therapy in children. Thromb Res 118 95-105
119. M Wang, T Hays, V Balasa, et al. (2003) for the Pediatric Coagulation Consortium. Experience using low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 25 379-386
120. H. Harmann, Becker Hussein, et al. (2001) Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Neonatal Ed 85 F18-F22
121. AA Gupta, M Leaker, M Andrew, et al. (2001) Safety and outcomes of thrombolysis with tissue plasminogen activator for the treatment of intravascular thrombosis in children. J Pediatr 139 682-688
122. F Ferari, F Vagnarelli, G Gargano, et al. (2001) Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator. Arch Dis Child Fetal Neonatal Ed 85 F66-F72
123. NA Goldenberg (2005) Long-term outcomes of venous thrombosis in children. Curr Opin Hematol 12 370-376
124. A Kosch, C Kuwertz-Bröking, Heller, et al. (2004) for the Childhood Thrombophilia Study Group. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 104 1356-1360
125. R Nuss, T Hays and M Manco-Johnson (1994) Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 16(2), 127-131
126. PJD Winyard, T Bharucha, R De Bruyn, et al. (2006) Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed 91 273-278
127. M Hausler, D Hubner, T Delhaas, et al. (2001) Long term complications of inferior vena cava thrombosis. Arch Dis Child 85 228-233
128. R Ramanaathan, TMD Hughes and AJ Richardson (2001) Perinatal inferior vena cava thrombosis and absence of the infrarenal inferior vena cava. J Vasc Surg 33 1097-1099